News

July 12, 2017July 13, 2017

FDA Expands Use of DigniCap to Prevent Chemotherapy-induced Hair Loss

News

The DigniCap Cooling System, a scalp-cooling system designed by Dignitana to reduce hair loss due to chemotherapy, was cleared by the U.S. Food and Drug Administration (FDA) to be used ... Read more

July 10, 2017July 10, 2017

BRCA1 and BRCA2 Mutations Increase Risk for Breast, Ovarian Cancers, Study Finds

News

Women who carry BRAC1 or BRAC2 genetic mutations have an increased risk of developing breast and ovarian cancers, according to a recent report published in JAMA. The study, “Risks of Breast, Ovarian, and Contralateral Breast ... Read more

July 7, 2017July 7, 2017

Celsion’s GEN-1 Combined with Chemotherapy May Help Treat Advanced Ovarian Cancer

News

Interim results of a clinical trial evaluating Celsion’s GEN-1 combined with preoperative chemotherapy to treat patients with advanced ovarian cancer were recently presented at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting. The ... Read more

July 5, 2017July 5, 2017

Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer

News

New data from the Phase 1 THINK clinical trial (NCT03018405) show that two metastatic colorectal cancer (mCRC) patients whose disease progressed following at least two prior therapies had stabilized the ... Read more

June 28, 2017

Half of Ovarian Cancer Patients Respond to Quisinostat Combo Therapy, Phase 2 Clinical Trial Shows

News

Half of patients with advanced ovarian cancer responded either fully or partially to a combination of quisinostat, Taxol (paclitaxel) and Paraplatin (carboplatin), according to a Phase 2 clinical trial. The ... Read more

June 26, 2017June 26, 2017

Actress Fran Drescher Headlines Tina’s Wish NYC Ovarian Cancer Fundraising Event

News

Tina’s Wish, a national nonprofit dedicated to funding scientific research for early detection of ovarian cancer, recently hosted 140 attendees at its annual Leadership Council Spring Reception. The June 15 event ... Read more

June 23, 2017June 23, 2017

PharmaMar’s Lurbinectedin to Be Marketed as Zepsyre After Approval as Ovarian Cancer Therapy

News

Once approved, PharmaMar’s lurbinectedin (PM1183) will be marketed under the brand name Zepsyre as a treatment for solid tumors in ovarian, lung, and breast cancers. Zepsyre is in its final stage of development as ... Read more

June 21, 2017June 21, 2017

Clovis to Apply for Expanded FDA Approval for Rubraca in Ovarian Cancer Patients

News

Clovis Oncology plans to apply to the U.S. Food and Drug Administration (FDA) for expanded approval of Rubraca (rucaparib) as a second-line and later maintenance treatment for all women with ... Read more

June 19, 2017June 19, 2017

CARMA Advances Funding for Development of Immunotherapy Program to Treat Metastatic Solid Tumors

News

CARMA Therapeutics has closed an initial financing, co-led by AbbVie Ventures and HealthCap, to build a pipeline of cancer programs using its proprietary chimeric antigen receptor targeting with macrophages (CARMA) ... Read more

June 16, 2017June 16, 2017

Geisinger Health System Hits Milestone with 150,000 Participants in Biobank and DNA Sequencing Study

News

Geisinger Health System announced that 150,000 participants have signed up for its comprehensive biobank and DNA sequencing study, known as the “MyCode Community Health Initiative.” The U.S. Centers for Disease Control ... Read more